tiprankstipranks
Trending News
More News >
Santen Pharmaceutical Co Ltd (SNPHY)
OTHER OTC:SNPHY

Santen Pharmaceutical Co (SNPHY) Revenue

Compare
5 Followers

Santen Pharmaceutical Co Revenue

Santen Pharmaceutical Co had a revenue of 76.37B in the quarter ending Dec 31, 2025, with 2.92%. This bring the company's revenue in the last twelve months to 301.90B, Decreased 3.92%. In the fiscal year ending Mar 31, 2025, Santen Pharmaceutical Co had annual revenue of 301.96B with 0.65% growth.
Revenue (ttm)
301.90B
Revenue Growth
-3.03%
P/S Ratio
0.01
Revenue/Employee
$80,653,045
Employees
3,744
Market Cap
$3.52B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Mar 31, 2025
301.96B1.96B+0.65%
Mar 31, 2025
300.00B20.97B+7.51%
Mar 31, 2024
279.04B12.78B+4.80%
Mar 31, 2023
266.26B16.65B+6.67%
Mar 31, 2022
249.60B8.05B+3.33%
Mar 31, 2021
241.56B7.53B+3.22%
Mar 31, 2020
234.03B9.08B+4.04%
Mar 31, 2019
224.94B25.85B+12.98%
Mar 31, 2017
199.10B